Globus Medical files pro forma financials for NuVasive Merger; combined net income $6M for 9 months

GLOBUS MEDICAL INC

Pro forma net income for nine months ended Sep 30, 2023: $6.0M ($0.04 diluted EPS) vs Globus standalone $107.8M.
Total purchase price $2.6B; goodwill $924M, intangible assets $1.22B (developed tech, customer relationships).
Pro forma net income for FY2022: $5.2M ($0.04 diluted EPS) vs Globus standalone $190.2M.
NuVasive contributed $827M revenue for Jan–Aug 2023; inventory step-up of $284M added to cost of sales.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.